Cellectis Correlations

CLLS Stock

USD 2.13 0.01 0.47%

The current 90-days correlation between Cellectis SA and DiaMedica Therapeutics is -0.01 (i.e., Good diversification). The correlation of Cellectis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Cellectis Correlation With Market

Good diversification

The correlation between Cellectis SA and DJI is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cellectis SA and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellectis SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Moving together with Cellectis Stock

0.69	ELAN	Elanco Animal Health	Pair Corr
0.68	HLN	Haleon plc	Pair Corr
0.61	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.81	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.68	TAK	Takeda Pharmaceutical	Pair Corr
0.64	LTRN	Lantern Pharma	Pair Corr
0.65	ANRO	Alto Neuroscience,	Pair Corr
0.66	SIGA	SIGA Technologies	Pair Corr

Moving against Cellectis Stock

0.88	EWTX	Edgewise Therapeutics	Pair Corr
0.8	BHC	Bausch Health Companies	Pair Corr
0.78	GILD	Gilead Sciences	Pair Corr
0.77	GANX	Gain Therapeutics	Pair Corr
0.71	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.7	EBS	Emergent Biosolutions	Pair Corr
0.64	ESPR	Esperion Therapeutics Buyout Trend	Pair Corr
0.49	WAT	Waters	Pair Corr
0.48	HCM	HUTCHMED DRC	Pair Corr
0.4	BCTXW	BriaCell Therapeutics	Pair Corr
0.35	BFRIW	Biofrontera Warrants	Pair Corr
0.64	CPRX	Catalyst Pharmaceuticals	Pair Corr
0.64	BSX	Boston Scientific Corp Sell-off Trend	Pair Corr
0.52	CMND	Clearmind Medicine Common	Pair Corr
0.43	ABT	Abbott Laboratories Sell-off Trend	Pair Corr
0.34	MNMD	Mind Medicine	Pair Corr

Related Correlations Analysis

	SGTX	DMAC	NBSE	SLNO	GNFT	CYT	ERYP	ELYM	HCWB	IPHA
SGTX		0.16	-0.8	0.4	-0.44	0.76	-0.39	-0.55	0.16	-0.61	SGTX
DMAC	0.16		-0.21	0.4	0.06	0.27	-0.25	-0.39	-0.07	-0.44	DMAC
NBSE	-0.8	-0.21		-0.56	0.3	-0.5	0.31	0.67	-0.05	0.72	NBSE
SLNO	0.4	0.4	-0.56		0.26	0.22	0.02	-0.65	-0.09	-0.68	SLNO
GNFT	-0.44	0.06	0.3	0.26		-0.4	0.28	-0.27	-0.31	-0.04	GNFT
CYT	0.76	0.27	-0.5	0.22	-0.4		-0.36	-0.42	0.28	-0.59	CYT
ERYP	-0.39	-0.25	0.31	0.02	0.28	-0.36		0.25	0.04	0.21	ERYP
ELYM	-0.55	-0.39	0.67	-0.65	-0.27	-0.42	0.25		-0.01	0.83	ELYM
HCWB	0.16	-0.07	-0.05	-0.09	-0.31	0.28	0.04	-0.01		-0.15	HCWB
IPHA	-0.61	-0.44	0.72	-0.68	-0.04	-0.59	0.21	0.83	-0.15		IPHA
	SGTX	DMAC	NBSE	SLNO	GNFT	CYT	ERYP	ELYM	HCWB	IPHA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

IPHA	+ 0.83	ELYM
CYT	+ 0.76	SGTX
IPHA	+ 0.72	NBSE
ELYM	+ 0.67	NBSE
SLNO	+ 0.4	SGTX
SLNO	+ 0.4	DMAC

High negative correlations

NBSE	- 0.8	SGTX
IPHA	- 0.68	SLNO
ELYM	- 0.65	SLNO
IPHA	- 0.61	SGTX
IPHA	- 0.59	CYT
SLNO	- 0.56	NBSE

Risk-Adjusted Indicators

There is a big difference between Cellectis Stock performing well and Cellectis Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cellectis' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
SGTX	14.93	1.14	0.71	0.16	6.43	(22.18)	12.46	(14.07)	442.39
DMAC	2.61	0.57	0.19	6.99	1.94	(3.23)	6.41	(3.29)	14.14
NBSE	4.27	(1.04)	0.00	(8.65)	0.00	0.00	8.42	(11.84)	39.09
SLNO	2.18	0.07	0.03	0.19	2.50	(2.39)	5.87	(4.22)	13.40
GNFT	2.89	(0.01)	(0.01)	0.12	4.52	(2.99)	6.17	(6.16)	30.76
CYT	2.76	0.43	0.12	0.52	2.57	(3.47)	10.00	(5.26)	36.14
ERYP	4.72	(0.05)	0.00	0.32	0.00	0.00	12.68	(8.25)	46.27
ELYM	3.87	(0.72)	0.00	0.69	0.00	0.00	6.21	(9.35)	34.87
HCWB	13.15	3.60	0.30	(0.91)	8.22	(23.56)	22.00	(16.67)	352.85
IPHA	3.64	(0.65)	0.00	(0.31)	0.00	0.00	7.96	(10.68)	29.50

Cellectis Corporate Management

MarieBleuenn Terrier	General Counsel, Member of the Executive Committee	Profile
Dr MBA	Chief Officer	Profile
Valerie Cros	Principal Officer	Profile
Kyung NamWortman	Executive Officer	Profile
Philippe Duchateau	Chief Scientific Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC